The primary analysis includes 64 patients with previously treated, advanced synovial sarcoma or myxoid/round cell liposarcoma ...

Following strong treatment response data for Adaptimmune’s lete-cel, the biotech is planning to initiate a rolling BLA ...

The study, which focused on the rare cancers synovial sarcoma and myxoid round cell liposarcoma (MRCLS), is published in The Lancet. "When these rare sarcomas have spread, patients have few ...

But three years later it was discovered he had a rare and aggressive synovial sarcoma tumour, which had spread to his lungs. Now 26 and cancer-free, Mr Spencer said: "It took 941 days for me to be ...